litlas
Log inCreate account

Lars Forsgren

Active 1983–2024

77
Papers
19,966
Citations
58
h-index
77
i10-index

Citations

Citations per year for Lars Forsgren1988: 1 citations1990: 1 citations1992: 5 citations1993: 8 citations1994: 4 citations1995: 13 citations1996: 25 citations1997: 34 citations1998: 16 citations1999: 20 citations2000: 24 citations2001: 24 citations2002: 38 citations2003: 39 citations2004: 33 citations2005: 69 citations2006: 64 citations2007: 66 citations2008: 77 citations2009: 87 citations2010: 65 citations2011: 103 citations2012: 120 citations2013: 113 citations2014: 132 citations2015: 163 citations2016: 190 citations2017: 194 citations2018: 202 citations2019: 699 citations2020: 766 citations2021: 699 citations2022: 595 citations2023: 459 citations2024: 761 citations2025: 314 citations2026: 22 citations1989: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,699 citing papers, 17.3% of this breakdownUnited Kingdom: 902 citing papers, 9.2% of this breakdownChina: 787 citing papers, 8% of this breakdownItaly: 544 citing papers, 5.5% of this breakdownGermany: 525 citing papers, 5.4% of this breakdownSweden: 512 citing papers, 5.2% of this breakdownCanada: 374 citing papers, 3.8% of this breakdownAustralia: 328 citing papers, 3.3% of this breakdownNetherlands: 312 citing papers, 3.2% of this breakdownFrance: 286 citing papers, 2.9% of this breakdownSpain: 242 citing papers, 2.5% of this breakdownIndia: 217 citing papers, 2.2% of this breakdown
0%17.3%Other 31.5%

Institutions

Fields

  • Medicine66.5%
  • Neuroscience19.3%
  • Biochemistry, Genetics and Molecular Biology9%
  • Health Professions0.8%
  • Computer Science0.7%
  • Immunology and Microbiology0.6%
  • Other3.1%

Topics

  • Epilepsy research and treatment11.3%
  • Parkinson's Disease Mechanisms and Treatments6.3%
  • Pharmacological Effects and Toxicity Studies5.2%
  • EEG and Brain-Computer Interfaces3.7%
  • Neuroscience and Neuropharmacology Research3.6%
  • Alzheimer's disease research and treatments3.2%
  • Other66.7%

Coauthors

All papers

Open in search
  1. ILAE Official Report: A practical clinical definition of epilepsy

    Authors: Robert S. Fisher, Carlos Alberto Acevedo, Alexis Arzimanoglou, Alicia Bogacz, J. Helen Cross, Christian E. Elger, Jerome Engel, Lars Forsgren, Jacqueline A. French, Mike Glynn, Dale C. Hesdorffer, B. I. Lee, Gary W. Mathern, Solomon L. Moshé, Emilio Perucca, Ingrid E. Scheffer, Torbjörn Tomson, Masako Watanabe, Samuel Wiebe - Epilepsia 2014 cited by 5,908

  2. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    Authors: Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg, Betty M. Tijms, Charlotte E. Teunissen, and the NFL Group, José C. Álvarez‐Cermeño, Ulf Andréasson, Markus Axelsson, David Bäckström, Aleš Bartoš, Maria Bjerke, Kaj Blennow, Adam L. Boxer, Lou Brundin, Joachim Burman, Tove Christensen, L Fialová, Lars Forsgren, Jette Lautrup Frederiksen, Magnus Gisslén, Elizabeth Gray, Martin Gunnarsson, Sara Hall, Oskar Hansson, Megan K. Herbert, Joel Jakobsson, Jan Jessen-Krut, Shorena Janelidze, Gudmundur Johannsson, Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kühle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching‐Hua Lu, Jan Lycke, Nadia Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josué Pérez‐Santiago, Fredrik Piehl, Yolande A.L. Pijnenburg, Okko T. Pyykkö, Óskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole Scherling, Jonathan M. Schott, Finn Sellebjerg, Isabella Laura Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vågberg, Marcel M. Verbeek, Luisa María Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsø, Edward J. Wild - JAMA Neurology 2019 cited by 760

  3. Blood-based NfL

    Authors: Oskar Hansson, Shorena Janelidze, Sara Hall, Nadia Magdalinou, Andrew J. Lees, Ulf Andréasson, Niklas Norgren, Jan Linder, Lars Forsgren, Radu Constantinescu, Henrik Zetterberg, Kaj Blennow, For the Swedish BioFINDER study - Neurology 2017 cited by 500

  4. Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

    Authors: Ettore Beghi, Anne T. Berg, Arturo Carpio, Lars Forsgren, Dale C. Hesdorffer, W. Allen Hauser, Kristina Malmgren, Shlomo Shinnar, Nancy Temkin, David J. Thurman, Torbjörn Tomson - Epilepsia 2005 cited by 2,315

  5. Recommendation for a definition of acute symptomatic seizure

    Authors: Ettore Beghi, Arturo Carpio, Lars Forsgren, Dale C. Hesdorffer, Kristina Malmgren, Josemir W. Sander, Torbjörn Tomson, W. Allen Hauser - Epilepsia 2009 cited by 904

  6. Gender differences in Parkinson's disease: A clinical perspective

    Authors: Dejan Georgiev, Katarina Hamberg, Marwan Hariz, Lars Forsgren, Gun‐Marie Hariz - Acta Neurologica Scandinavica 2017 cited by 224

  7. NfL as a biomarker for neurodegeneration and survival in Parkinson disease

    Authors: David Bäckström, Jan Linder, Susanna Jakobson Mo, Katrine Riklund, Henrik Zetterberg, Kaj Blennow, Lars Forsgren, Niklas Lenfeldt - Neurology 2020 cited by 141

  8. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study

    Authors: Aleksandra A. Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, Marta Camacho, David Bäckström, Lars Forsgren, Charalampos Tzoulis, Sophie Winder‐Rhodes, Gavin Hudson, Ganqiang Liu, Clemens R. Scherzer, Rachael Lawson, Alison J. Yarnall, Caroline H. Williams‐Gray, Angus D. Macleod, Carl Counsell, Ole‐Bjørn Tysnes, Guido Alves, Jodi Maple‐Grødem - Movement Disorders 2022 cited by 120

  9. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

    Authors: David Bäckström, Magdalena Eriksson Domellöf, Jan Linder, Bob Olsson, Annika Öhrfelt, Miles Trupp, Henrik Zetterberg, Kaj Blennow, Lars Forsgren - JAMA Neurology 2015 cited by 196

  10. Early predictors of mortality in parkinsonism and Parkinson disease

    Authors: David Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, Jan Linder, Susanna Jakobson Mo, Katrine Riklund, Henrik Zetterberg, Kaj Blennow, Lars Forsgren - Neurology 2018 cited by 169

  11. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders

    Authors: Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, Protik Jakobsson, Wagner S. Brum, Johan Gobom, Lars Forsgren, Keti Dalla, Radu Constantinescu, Henrik Zetterberg, Oskar Hansson, Kaj Blennow, David Bäckström, Ann Brinkmalm - Movement Disorders 2022 cited by 58

  12. Exploring causality of the association between smoking and Parkinson’s disease

    Authors: V. Gallo, Paolo Vineis, Mariagrazia Cancellieri, Paolo Chiodini, Roger A. Barker, Carol Brayne, Neil Pearce, Roel Vermeulen, Salvatore Panico, Bas Bueno‐de‐Mesquita, Nicola Vanacore, Lars Forsgren, Silvia Ramat, Eva Ardanáz, Larraitz Arriola, Jesper Peterson, Oskar Hansson, Diana Gavrila, Carlotta Sacerdote, Sabina Sieri, Tilman Kühn, Verena Katzke, Yvonne T. van der Schouw, Andreas Kyrozis, Giovanna Masala, Amalia Mattiello, Robert Perneczky, Lefkos Middleton, Rodolfo Saracci, Elio Ríboli - International Journal of Epidemiology 2018 cited by 141

  13. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up

    Authors: Magnus Domellöf, Urban Ekman, Lars Forsgren, Eva Elgh - Acta Neurologica Scandinavica 2015 cited by 145

  14. Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson’s Disease

    Authors: Miles Trupp, Pär Jonsson, Annika Öhrfelt, Henrik Zetterberg, Ogonna Obudulu, Linus Malm, Anna Wuolikainen, Jan Linder, Thomas Möritz, Kaj Blennow, Henrik Antti, Lars Forsgren - Journal of Parkinson s Disease 2014 cited by 145

  15. Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson’s disease: a randomised blinded evaluation

    Authors: Patric Blomstedt, Rasmus Stenmark Persson, Gun‐Marie Hariz, Jan Linder, Anna Fredricks, Björn Häggström, Johanna Philipsson, Lars Forsgren, Marwan Hariz - Journal of Neurology Neurosurgery & Psychiatry 2018 cited by 98

  16. An altered immune response to Epstein-Barr virus in multiple sclerosis

    Authors: Peter Sundström, Per Juto, Göran Wadell, G. Hallmans, Anders Svenningsson, L. Nyström, Joakim Dillner, Lars Forsgren - Neurology 2004 cited by 303

  17. Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS

    Authors: Shaochun Zhu, Anna Wuolikainen, Junfang Wu, Anders Öhman, Gunnar Wingsle, Thomas Möritz, Peter M. Andersen, Lars Forsgren, Miles Trupp - Journal of Molecular Neuroscience 2019 cited by 55

  18. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study

    Authors: David Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, Katrine Riklund, Miles Trupp, Henrik Zetterberg, Kaj Blennow, Lars Forsgren, Magdalena Eriksson Domellöf - Brain Communications 2022 cited by 35

  19. The epidemiology of epilepsy in Europe – a systematic review

    Authors: Lars Forsgren, Ettore Beghi, Andre Õun, Matti Sillanpää - European Journal of Neurology 2005 cited by 799

  20. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

    Authors: Christina M. Lill, Aina Rengmark, Lasse Pihlstrøm, Isabella Fogh, Aleksey Shatunov, Patrick Sleiman, Li‐San Wang, Tian Liu, Christina Funch Lassen, Esther Meissner, Panos Alexopoulos, Andrea Calvo, Adriano Chiò, Nil Dizdar, Frank Faltraco, Lars Forsgren, Julia Kirchheiner, Alexander Kurz, Jan Larsen, Maria Liebsch, Jan Linder, Karen Morrison, Hans Nissbrandt, Markus Otto, Jens Pahnke, Amanda Partch, Gabriella Restagno, Dan Rujescu, Cathrin Schnack, Christopher E. Shaw, Pamela J. Shaw, Hayrettin Tumani, Ole‐Bjørn Tysnes, Otto Valladares, Vincenzo Silani, Leonard H. van den Berg, Wouter van Rheenen, Jan H. Veldink, Ulman Lindenberger, Elisabeth Steinhagen‐Thiessen, Stefan Teipel, Robert Perneczky, Håkon Håkonarson, Harald Hampel, Christine A. F. Von Arnim, Jørgen H. Olsen, Vivianna M. Van Deerlin, Ammar Al‐Chalabi, Mathias Toft, Beate Ritz, Lars Bertram - Alzheimer s & Dementia 2015 cited by 206

  21. Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease

    Authors: Sok Kean Khoo, David Petillo, Un Jung Kang, James H. Resau, Brian Berryhill, Jan Linder, Lars Forsgren, Leslie A. Neuman, Aik Choon Tan - Journal of Parkinson s Disease 2012 cited by 196

  22. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study

    Authors: Urban Ekman, Johan Eriksson, Lars Forsgren, Susanna Jakobson Mo, Katrine Riklund, Lars Nyberg - The Lancet Neurology 2012 cited by 169

  23. α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients

    Authors: Wojciech Pasławski, Justyna Zarȩba-Pasławska, Xiaoqun Zhang, Katharina Hölzl, Henrik Wadensten, Mohammadreza Shariatgorji, Shorena Janelidze, Oskar Hansson, Lars Forsgren, Per E. Andrén, Per Svenningsson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 63

  24. Plasma Metabolite Markers of Parkinson’s Disease and Atypical Parkinsonism

    Authors: Meerakhan Pathan, Junfang Wu, Hans‐Åke Lakso, Lars Forsgren, Anders Öhman - Metabolites 2021 cited by 26